Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Novak

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 21, 2004
ADAM proteins in the brainUlrike Novak
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 3, 2004
Targeted therapy for malignant gliomasAndrew P Morokoff, Ulrike Novak
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 3, 2002
EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell linesDina Tsatas, Varuni Kanagasundaram, Andrew Kaye, et al.
Journal of Cell Science|July 27, 2006
Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family membersNathan J Gödde, Giovanna M D'Abaco, Lucy Paradiso, et al.
Neurosurgery|December 31, 2005
ADAM22, expressed in normal brain but not in high-grade gliomas, inhibits cellular proliferation via the disintegrin domainGiovanna M D'Abaco, Ken Ng, Lucy Paradiso, et al.
Neurosurgery|May 23, 2002
Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activityBouchra Enegd, James A J King, Stan Stylli, et al.
Cancer|August 5, 2005
Caspase 8 is absent or low in many ex vivo gliomasDavid M Ashley, Christopher D Riffkin, Andrea M Muscat, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 21, 2004
ADAM proteins in the brainUlrike Novak
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 3, 2004
Targeted therapy for malignant gliomasAndrew P Morokoff, Ulrike Novak
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 3, 2002
EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell linesDina Tsatas, Varuni Kanagasundaram, Andrew Kaye, et al.
Journal of Cell Science|July 27, 2006
Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family membersNathan J Gödde, Giovanna M D'Abaco, Lucy Paradiso, et al.
Neurosurgery|December 31, 2005
ADAM22, expressed in normal brain but not in high-grade gliomas, inhibits cellular proliferation via the disintegrin domainGiovanna M D'Abaco, Ken Ng, Lucy Paradiso, et al.
Neurosurgery|May 23, 2002
Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activityBouchra Enegd, James A J King, Stan Stylli, et al.
Cancer|August 5, 2005
Caspase 8 is absent or low in many ex vivo gliomasDavid M Ashley, Christopher D Riffkin, Andrea M Muscat, et al.
Pageof 1